Prevalence of hormonal and endocrine dysfunction in patients with lichen planopilaris (LPP): A retrospective data analysis of 168 patients - 18/04/17
Abstract |
Background |
Studies on the pathophysiology and comorbidities associated with lichen planopilaris (LPP) and frontal fibrosing alopecia (FFA) are limited.
Objective |
The purpose of this study was to determine the prevalence of androgen excess in the postmenopausal LPP population, in relation to demographics and comorbidities.
Methods |
A retrospective data analysis of 413 patients with LPP, FFA, and LPP/FFA seen in the Department of Dermatology at the Cleveland Clinic Foundation in Ohio between 2005 and 2015 was conducted. Of this cohort, 168 patients met the inclusion criteria.
Results |
Androgen excess was identified in 31.5% (n = 53) of the 168 patients with LPP and all subtypes (P < .001). Androgen deficiency was identified in 32.1% (n = 17) of the 53 patients with FFA (P < .001). The androgen excess group was significantly more likely to present with hirsutism, seborrheic dermatitis, polycystic ovary syndrome, ovarian cysts, or a combination of these (P < .001).
Limitations |
This study was limited by being retrospective.
Conclusion |
Our study demonstrated that LPP is associated with androgen excess, and FFA is associated with androgen deficiency.
Le texte complet de cet article est disponible en PDF.Key words : androgens, frontal fibrosing alopecia, lichen planopilaris, polycystic ovary syndrome, postmenopausal
Abbreviations used : DHEAS, FFA, LPP, PCOS
Plan
| Supported by Dermatology Plastics Surgery Institute (grant 10- 160). |
|
| Conflicts of interest: None declared. |
Vol 76 - N° 2
P. 314-320 - février 2017 Retour au numéro
Article précédent
- Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa
- Alexander H. Fischer, Alessandra Haskin, Ginette A. Okoye
- Treatment of recalcitrant port-wine stains (PWS) using a combined pulsed dye laser (PDL) and radiofrequency (RF) energy device
- Yoon-Soo Cindy Bae, Hamad Alabdulrazzaq, Jeremy A. Brauer, Roy G. Geronemus
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?